List of Excipients in API abemaciclib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing abemaciclib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Eli Lilly and Company | VERZENIO | abemaciclib | 0002-4483 | CELLULOSE, MICROCRYSTALLINE | 2031-09-28 |
| Eli Lilly and Company | VERZENIO | abemaciclib | 0002-4483 | CROSCARMELLOSE SODIUM | 2031-09-28 |
| Eli Lilly and Company | VERZENIO | abemaciclib | 0002-4483 | FERRIC OXIDE RED | 2031-09-28 |
| Eli Lilly and Company | VERZENIO | abemaciclib | 0002-4483 | FERRIC OXIDE YELLOW | 2031-09-28 |
| Eli Lilly and Company | VERZENIO | abemaciclib | 0002-4483 | LACTOSE MONOHYDRATE | 2031-09-28 |
| Eli Lilly and Company | VERZENIO | abemaciclib | 0002-4483 | POLYETHYLENE GLYCOL | 2031-09-28 |
| Eli Lilly and Company | VERZENIO | abemaciclib | 0002-4483 | POLYVINYL ALCOHOL | 2031-09-28 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for abemaciclib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
abemaciclib drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | abemaciclib | 0002-4483 |
| >Company | >Ingredient | >NDC |
abemaciclib drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
abemaciclib drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | abemaciclib | 0002-4483 |
| >Company | >Ingredient | >NDC |
abemaciclib drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
abemaciclib drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | abemaciclib | 0002-4483 |
| >Company | >Ingredient | >NDC |
abemaciclib drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
abemaciclib drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | abemaciclib | 0002-4483 |
| >Company | >Ingredient | >NDC |
abemaciclib drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
abemaciclib drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | abemaciclib | 0002-4483 |
| >Company | >Ingredient | >NDC |
abemaciclib drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
abemaciclib drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | abemaciclib | 0002-4483 |
| >Company | >Ingredient | >NDC |
abemaciclib drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
abemaciclib drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | abemaciclib | 0002-4483 |
| >Company | >Ingredient | >NDC |
abemaciclib drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
abemaciclib drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | abemaciclib | 0002-4483 |
| >Company | >Ingredient | >NDC |
abemaciclib drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
abemaciclib drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | abemaciclib | 0002-4483 |
| >Company | >Ingredient | >NDC |
abemaciclib drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
abemaciclib drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | abemaciclib | 0002-4483 |
| >Company | >Ingredient | >NDC |
abemaciclib drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
abemaciclib drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | abemaciclib | 0002-4483 |
| >Company | >Ingredient | >NDC |
abemaciclib drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
abemaciclib drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | abemaciclib | 0002-4483 |
| >Company | >Ingredient | >NDC |
abemaciclib drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch